With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in different areas across the country and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak.
The webinar featured contributions from the following speakers:
• Mark Gillyon-Powell - Head of Programme, HCV Elimination, NHS England & NHS Improvement
• Dr Steve Ryder - Chair, HCV Action and Clinical Lead, Nottingham Hepatitis C ODN
Hepatitis C treatment monitoring in England
Download
This Public Health England resource contains data and findings from the hepatitis C patient registry and treatment outcome system. Data from the registry shows that DAA treatments have successfully cured 95% of patients who received them. The vast majority of treatment continues to take place within secondary care, with just 13% of treatments undertaken in drug services, prisons or other outreach settings.
